CBDW — 1606 Income Statement
0.000.00%
- $0.65m
- $2.09m
- $0.00m
Annual income statement for 1606, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.034 | 0.068 | 0.034 | 0.014 | 0.002 |
Cost of Revenue | |||||
Gross Profit | 0.009 | 0.016 | 0.012 | 0.001 | 0.001 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.229 | 0.296 | 0.335 | 0.554 | 1.78 |
Operating Profit | -0.195 | -0.228 | -0.301 | -0.54 | -1.77 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.195 | -0.228 | -0.301 | -0.54 | -1.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.195 | -0.228 | -0.301 | -0.54 | -1.58 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.195 | -0.228 | -0.301 | -0.54 | -1.58 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.195 | -0.228 | -0.301 | -0.54 | -1.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.006 | -0.007 | -0.009 | -0.032 |